Patent · US Active

Oral cholestyramine formulation and use thereof

US10786529B2 · kind B2 · utility

11Cited by

49References

25Claims

0Family size

Assignee

ALBIREO AB · SE

Inventors

Per-Göran Gillberg · Timrå, SE
Nils Ove Gustafsson · Löddeköpinge, SE
Nils-Olof Lindberg · Malmö, SE
Jessica Elversson · Dalby, SE

Key dates

Filing date	Mar 3, 2017
Grant date	Sep 29, 2020
Priority date	—
Expiry date	Mar 3, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/785
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a diffusion-controlled inner coating and an enteric outer coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.